Venous sinus thrombosis after the second jab of an mRNA-based SARS-CoV-2 vaccine

OBJECTIVES: Venous sinus thrombosis (VST) after vaccination with the mRNA-based vaccine produced by Pfizer is comparatively rare and usually occurs after the first dose. VST after the second dose has been reported in only few patients. CASE REPORT: The patient is a 33yo male who experienced an episo...

Descripción completa

Detalles Bibliográficos
Autores principales: Finsterer, Josef, Nics, Sebastian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Hemorrhagic Stroke Association. Publishing services by Elsevier B.V. on behalf of KeAi Communications Co. Ltd. 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8651552/
https://www.ncbi.nlm.nih.gov/pubmed/34901793
http://dx.doi.org/10.1016/j.hest.2021.12.001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8651552/
https://www.ncbi.nlm.nih.gov/pubmed/34901793
http://dx.doi.org/10.1016/j.hest.2021.12.001

Ejemplares similares